Exclusive

Publication

Byline

Thomas and Uber Cup Finals 2026: India men take on Canada, women face Denmark on opening day

New Delhi, April 23 -- India's men's and women's teams are set to begin their campaigns at the Thomas Cup and Uber Cup Finals 2026, with the spotlight firmly on the opening day in Horsens, Denmark. T... Read More


Keralam: 37-year-old man dies of sunstroke in Kannur

Kannur, April 23 -- A 37-year-old man undergoing treatment for sunstroke died on Thursday morning, marking a heat-related fatality in the district amid rising temperatures. The deceased has been iden... Read More


Rethinking Governance in PunjabPublished on: April 23, 2026 10:04 AM

Pakistan, April 23 -- Punjab is in the midst of an ambitious governance experiment that seeks to combine digital transformation, welfare expansion, and youth-focused policymaking into a coherent visio... Read More


Nifty trades below 24,300 level; consumer durables shares decline

Mumbai, April 23 -- The key domestic indices continued to trade with moderate losses in early trade as investor sentiment remained cautious amid uncertainty over the reopening of the Strait of Hormuz ... Read More


IPL 2026: CSK sign Akash Madhwal as replacement for Ayush Mhatre

Mumbai, April 23 -- Chennai Super Kings (CSK) have signed Akash Madhwal as a replacement for Ayush Mhatre, who has been ruled out of the remainder of the Indian Premier League (IPL) 2026 due to a hams... Read More


Over 36,000 participants gear up for 18th edition of World 10K Bengaluru

Bengaluru, April 23 -- The 18th edition will be flagged off from the Field Marshal Sam Manekshaw Parade Ground and is set to witness a record participation of over 36,000 runners in the Garden City on... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 23 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 23 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 23 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 23 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More